Does TORSEMIDE Cause Interstitial lung disease? 32 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 32 reports of Interstitial lung disease have been filed in association with TORSEMIDE (Torsemide). This represents 0.4% of all adverse event reports for TORSEMIDE.
32
Reports of Interstitial lung disease with TORSEMIDE
0.4%
of all TORSEMIDE reports
0
Deaths
25
Hospitalizations
How Dangerous Is Interstitial lung disease From TORSEMIDE?
Of the 32 reports, 25 (78.1%) required hospitalization, and 3 (9.4%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TORSEMIDE. However, 32 reports have been filed with the FAERS database.
What Other Side Effects Does TORSEMIDE Cause?
General physical health deterioration (1,233)
Dyspnoea (1,176)
Acute kidney injury (975)
Dizziness (870)
Oedema peripheral (823)
Fall (707)
Dehydration (705)
Cardiac failure (698)
Hypotension (689)
Fatigue (635)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which TORSEMIDE Alternatives Have Lower Interstitial lung disease Risk?
TORSEMIDE vs TOVIAZ
TORSEMIDE vs TOVORAFENIB
TORSEMIDE vs TOZINAMERAN
TORSEMIDE vs TRABECTEDIN
TORSEMIDE vs TRACLEER